Cargando…
Lentiviral Vector-Mediated Correction of a Mouse Model of Leukocyte Adhesion Deficiency Type I
Leukocyte adhesion deficiency type I (LAD-I) is a primary immunodeficiency caused by mutations in the ITGB2 gene and is characterized by recurrent and life-threatening bacterial infections. These mutations lead to defective or absent expression of β(2) integrins on the leukocyte surface, compromisin...
Autores principales: | Leon-Rico, Diego, Aldea, Montserrat, Sanchez-Baltasar, Raquel, Mesa-Nuñez, Cristina, Record, Julien, Burns, Siobhan O., Santilli, Giorgia, Thrasher, Adrian J., Bueren, Juan A., Almarza, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035374/ https://www.ncbi.nlm.nih.gov/pubmed/27056660 http://dx.doi.org/10.1089/hum.2016.016 |
Ejemplares similares
-
Preclinical safety and efficacy of lentiviral-mediated gene therapy for leukocyte adhesion deficiency type I
por: Mesa-Núñez, Cristina, et al.
Publicado: (2022) -
The downregulated membrane expression of CD18 in CD34(+) cells defines a primitive population of human hematopoietic stem cells
por: Mesa-Núñez, Cristina, et al.
Publicado: (2020) -
WAS Promoter-Driven Lentiviral Vectors Mimic Closely the Lopsided WASP Expression during Megakaryocytic Differentiation
por: Muñoz, Pilar, et al.
Publicado: (2020) -
Construction of stable packaging cell lines for clinical lentiviral vector production
por: Sanber, Khaled S., et al.
Publicado: (2015) -
Enhancing Lentiviral and Alpharetroviral Transduction of Human Hematopoietic Stem Cells for Clinical Application
por: Schott, Juliane W., et al.
Publicado: (2019)